- Metabolite
- HMDB0000326 (1b,3a,12a-Trihydroxy-5b-cholanoic acid)
- Biospecimen
- Blood
- Status
- Detected and Quantified
- Data source
- Referenced
- Concentration
- 0.8 (0.2-2.0) uM
- Age
- Adult (>18 years old)
- Sex
- Both
- Condition
- Biliary cirrhosis
Comments
Patients with biliary cirrhosis before ursodeoxycholic acid treatment
References
- Batta AK, Arora R, Salen G, Tint GS, Eskreis D, Katz S: Characterization of serum and urinary bile acids in patients with primary biliary cirrhosis by gas-liquid chromatography-mass spectrometry: effect of ursodeoxycholic acid treatment. J Lipid Res. 1989 Dec;30(12):1953-62. [PubMed:2621422 ]